Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 2.1 Description of Securities Registered Under Section 12 of the Exchange Act
- 4.24 Second Amendment to Asset Purchase Agreement Between Genomic Health, Inc. and Mdxhealth Dated August 23, 2023
- 12.1 Certification
- 12.2 Certification
- 13.1 Certification
- 13.2 Certification
- 15.1 Consent of Bdo Reviseurs D'entreprises SRL, Independent Registered Public Accounting Firm
- 97.1 Incentive-based Compensation Recovery Policy, Effective As of December 1, 2023
- Download Excel data file
- View Excel data file
Associated MDXH transcripts
MDXH similar filings
Filing view
External links
Exhibit 15.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
MDxHealth SA
Herstal, Belgium
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated April 30, 2024 included in this Form 20-F in the Registration Statement (Form F-3, File No. 333-268885).
BDO Réviseurs d’Entreprises SRL
On behalf of it,
/s/ Bert Kegels
Zaventem, Belgium
April 30, 2024